Abstract: This invention relates to prophylactic and/or therapeutic application of microorganism species that are, for example, administered orally as delayed release formulation designed to release its microbial content to the distal small intestine and/or colon in high quantities and density, which is a “normalized” approach to repopulate the colonic flora as a method of prevention and/or treatment of, for example, Clostridium difficile colitis.
Type:
Application
Filed:
October 22, 2012
Publication date:
April 24, 2014
Applicant:
POLONEZ THERAPEUTICS LLC
Inventors:
Wieslaw J. Bochenek, Michael L. Corrado